Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the changes in foreign holdings of TWSE Stocks as of Apr 5th which has an aggregated holding worth USD3,983.2bn.</li>
<li>We estimate that foreign flows to be outflows of USD232mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign instutions.</li>
<li>We highlight foreign changes in TSMC, Wiwynn, Bora Pharma, Wistron, Faraday Tech, Lite-On Tech, Alchip Tech, Hon Hai, Asia Vital, Quanta Computer.</li>
</ul>


We analyzed the changes in foreign holdings of TWSE Stocks as of Apr 5th which has an aggregated holding worth USD3,983.2bn.
We estimate that foreign flows to be outflows of USD232mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign instutions.
We highlight foreign changes in TSMC, Wiwynn, Bora Pharma, Wistron, Faraday Tech, Lite-On Tech, Alchip Tech, Hon Hai, Asia Vital, Quanta Computer.


TWSE Foreign Holding Weekly (Apr 5th): TSMC, Wiwynn, Bora Pharma, Wistron, Faraday Tech, Lite-On

<ul>
<li>We analyzed the changes in short interest of TWSE Stocks as of Mar 29th which has an aggregated short interest worth USD76.9bn.</li>
<li>We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Evergreen Marine, United Integrate, Chicony Elec, Unimicron Tech, Hon Hai, Global Unichip, Asia Vital.</li>
</ul>


We analyzed the changes in short interest of TWSE Stocks as of Mar 29th which has an aggregated short interest worth USD76.9bn.
We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Evergreen Marine, United Integrate, Chicony Elec, Unimicron Tech, Hon Hai, Global Unichip, Asia Vital.


TWSE Short Interest Weekly (Mar 29th): Evergreen Marine, United Integrate, Chicony Elec, Unimicron

<ul>
<li>We analyzed the changes in short interest of TWSE Stocks as of Mar 22nd which has an aggregated short interest worth USD73.8bn.</li>
<li>We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Evergreen Marine, Getac Holdings, Lite-On Tech, Nanya Tech, Alchip Tech, TSMC, Chung-Hsin.</li>
</ul>


We analyzed the changes in short interest of TWSE Stocks as of Mar 22nd which has an aggregated short interest worth USD73.8bn.
We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Evergreen Marine, Getac Holdings, Lite-On Tech, Nanya Tech, Alchip Tech, TSMC, Chung-Hsin.


TWSE Short Interest Weekly (Mar 22nd): Evergreen Marine, Getac Holdings, Lite-On Tech, Nanya Tech

Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/lotus-pharmaceutical-co-ltd" target="_blank" data-smartkarma-citation="entities:20568:1" rel="noopener">Lotus Pharmaceutical (1795 TT)</a> achieved 16% revenue growth to NT$17B in 2023, while net profit increased 36% to NT$4B. Growth was mainly driven by the strong performance of Asian business.</li>
<li>For the first two months of 2024, the company reported revenue of NT$3B, representing 1% YoY decline. While exports grew, Asia business remained flat. </li>
<li>1Q24 should be flat or slightly negative for the company, while growth is expected to pick up from the later half of the year.</li>
</ul>



Lotus Pharmaceutical (1795 TT) achieved 16% revenue growth to NT$17B in 2023, while net profit increased 36% to NT$4B. Growth was mainly driven by the strong performance of Asian business.
For the first two months of 2024, the company reported revenue of NT$3B, representing 1% YoY decline. While exports grew, Asia business remained flat. 
1Q24 should be flat or slightly negative for the company, while growth is expected to pick up from the later half of the year.


Lotus Pharmaceutical (1795 TT): Record-High Performance in 2023; What Lies Ahead?

Taiwan

Bora Pharmaceuticals Co Ltd is a pharmaceutical company. The Company researches, manufactures and sell proprietary pharmaceuticals.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bora Pharmaceuticals (6472 TT)

TWSE Foreign Holding Weekly (Apr 5th): TSMC, Wiwynn, Bora Pharma, Wistron, Faraday Tech, Lite-On

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Wiwynn, Bora Pharma, Wistron, Faraday...

Ke Yan, CFA, FRM

TWSE Short Interest Weekly (Mar 29th): Evergreen Marine, United Integrate, Chicony Elec, Unimicron

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Evergreen Marine, United Integrate, Chicony...

Ke Yan, CFA, FRM

TWSE Short Interest Weekly (Mar 29th): Evergreen Marine, United Integrate, Chicony Elec, Unimicron

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Evergreen Marine, United Integrate, Chicony...

Ke Yan, CFA, FRM

TWSE Short Interest Weekly (Mar 22nd): Evergreen Marine, Getac Holdings, Lite-On Tech, Nanya Tech

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Evergreen Marine, Getac Holdings, Lite-On Tech,...

Ke Yan, CFA, FRM

Lotus Pharmaceutical (1795 TT): Record-High Performance in 2023; What Lies Ahead?

Lotus achieved 16% and 36%, YoY, revenue and profit growth, respectively, in 2023. The company is facing slight revenue decline in early 2024,...

Tina Banerjee

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

TWSE Foreign Holding Weekly (Apr 5th): TSMC, Wiwynn, Bora Pharma, Wistron, Faraday Tech, Lite-On

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Wiwynn, Bora Pharma, Wistron, Faraday...

Ke Yan, CFA, FRM

TWSE Short Interest Weekly (Mar 29th): Evergreen Marine, United Integrate, Chicony Elec, Unimicron

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Evergreen Marine, United Integrate, Chicony...

Ke Yan, CFA, FRM

TWSE Short Interest Weekly (Mar 29th): Evergreen Marine, United Integrate, Chicony Elec, Unimicron

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Evergreen Marine, United Integrate, Chicony...

Ke Yan, CFA, FRM

TWSE Short Interest Weekly (Mar 22nd): Evergreen Marine, Getac Holdings, Lite-On Tech, Nanya Tech

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Evergreen Marine, Getac Holdings, Lite-On Tech,...

Ke Yan, CFA, FRM

Lotus Pharmaceutical (1795 TT): Record-High Performance in 2023; What Lies Ahead?

​Lotus achieved 16% and 36%, YoY, revenue and profit growth, respectively, in 2023. The company is facing slight revenue decline in early 2024,...

Tina Banerjee

Lotus achieved 16% and 36%, YoY, revenue and profit growth, respectively, in 2023. The company is facing slight revenue decline in early 2024,...